X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ELDN

Closed

Eledon Pharmaceuticals Inc

2.79
+0.08 (+2.95%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.71
Day's Range: 2.64 - 2.825
Send
When Written:
 
2.36
Eledon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on developing treatments for patients with cancer and other diseases. The company's lead product candidate, AT-007, is an investigational therapy for the treatment of rare and serious metabolic disorders. AT-007 is currently in Phase 2 clinical trials.

Eledon Pharmaceuticals Inc was founded in 2018 and is headquartered in San Diego, California. The company's mission is to develop innovative therapies that improve the lives of patients with unmet medical needs. Eledon Pharmaceuticals Inc is led by a team of experienced industry professionals with a proven track record of developing and commercializing successful therapies.

In addition to AT-007, Eledon Pharmaceuticals Inc is also developing other product candidates for the treatment of cancer and other diseases. The company is committed to advancing its pipeline of innovative therapies through rigorous scientific research and clinical development.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X